CPHI vs DOW · rev $4.1M vs P/E 74, rev $42.96B
China Pharma Holdings Inc (CPHI) versus Dow Inc (DOW) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
Dow Inc (DOW) is a chemicals company listed on US.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
Latest reported DOW revenue for 2024-12-31 was $42.96B. Net income was $1.20B. Revenue was down 3.7% from 2023-12-31 to 2024-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
CPHI currently screens at market cap $29.0M. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
Not investment advice. Open the CPHI and DOW stock pages for the full models.
Not investment advice.